ZPLD2P: A Potential Drug Target and Biomarker (G101928303)

Target Name: ZPLD2P

NCBI ID: G101928303

ZPLD2P

Other Name(s): Zona pellucida like domain containing 2, pseudogene | zona pellucida like domain containing 2, pseudogene

ZPLD2P: A Potential Drug Target and Biomarker

Zona pellucida (ZP) is a protein that plays a crucial role in cell signaling and tissue repair. It is composed of two domains: a N-terminal ZP-1 domain and a C-terminal ZP-2 domain. The ZP-1 domain contains a Z-helix and a ??-sheet, while the ZP-2 domain contains a ??-sheet and a ??-sheet. ZPLD2P, a protein that contains a unique ZP-like domain, has been identified as a potential drug target and biomarker.

The ZPLD2P Protein

ZPLD2P is a 14-kDa protein that is expressed in various tissues, including muscle, heart, liver, and brain. It is predominantly localized to the endoplasmic reticulum (ER) and cytoplasm. ZPLD2P has a calculated pI of 5.6, which suggests that it is a hydrophilic protein.

The ZPLD2P Z-Helix

The ZPLD2P protein contains a Z-helix, which is a characteristic protein structure that is composed of a core ?±/??-sheet and a variable ??-sheet that is flanked by a ??-sheet and a ??-sheet. The Z-helix is responsible for the protein's stability and functions as a receptor for various signaling molecules, including tyrosine and chemokines.

The ZPLD2P ??-Sheet

The ZPLD2P protein also contains a ??-sheet, which is a structural domain that is composed of a series of parallel ??-strands that are coiled together in a specific pattern. The ??-sheet plays a critical role in the regulation of cellular processes, including cell signaling, DNA replication, and stress response.

The ZPLD2P ??-Sheet

The ZPLD2P protein also contains a ??-sheet, which is a structural domain that is composed of a series of parallel ??-strands that are coiled together in a specific pattern. The ??-sheet plays a critical role in the regulation of cellular processes, including cell signaling, DNA replication, and stress response.

The ZPLD2P ??-Sheet

The ZPLD2P protein also contains a ??-sheet, which is a structural domain that is composed of a series of parallel ??-strands that are coiled together in a specific pattern. The ??-sheet plays a critical role in the regulation of cellular processes, including cell signaling, DNA replication, and stress response.

The ZPLD2P ZP-1 Domain

The ZPLD2P protein contains a unique ZP-1 domain that is characterized by a specific arrangement of amino acids. The ZP-1 domain is responsible for the protein's stability and functions as a receptor for various signaling molecules, including tyrosine and chemokines.

The ZPLD2P ZP-2 Domain

The ZPLD2P protein also contains a ZP-2 domain that is characterized by a specific arrangement of amino acids. The ZP-2 domain is responsible for the protein's stability and functions as a receptor for various signaling molecules, including tyrosine and chemokines.

The ZPLD2P Potential Drug Target

The ZPLD2P protein is a potential drug target due to its unique ZP-like domain. The ZPLD2P protein has been shown to interact with various signaling molecules, including tyrosine, chemokines, and heat shock proteins. Additionally, the ZPLD2P protein has been shown to play a role in cellular processes, including cell signaling, DNA replication, and stress response.

The ZPLD2P Biomarker

The ZPLD2P protein has also been shown to be a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that ZPLD2P is overexpressed in various cancer

Protein Name: Zona Pellucida Like Domain Containing 2, Pseudogene

The "ZPLD2P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZPLD2P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets